heavy particles used transcutaneous radiotherapy NUMBER years particles pi mesons remain domain highly specialized centers neutron therapy lesser degree proton therapy considered common clinical protocols limits complications efficacities costs sufficiently known encourage centers acquire necessary equipment practical advantages involve limited number patients patients implicated prognoses appreciably improved application therapies radiotherapy limited poor technical capabilities currently available hyperthermia machines biological experimentation highly promising clinical results date unfulfilling nonetheless interstitial radiotherapy represents interesting clinical possibility radiosensitizers extensively developed results randomized therapeutic trials contradictory toxicity products renders use difficult new products tested lower toxicity potent radiosensitization capacity encouraging future use class compounds hyperthermia associated hyperthermia associated